HNGE
Income statement / Annual
Last year (2025), Hinge Health Inc.'s total revenue was $587.86 M,
an increase of 50.58% from the previous year.
In 2025, Hinge Health Inc.'s net income was -$528.26 M.
See Hinge Health Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
| Operating Revenue |
$587.86 M |
$390.40 M |
$292.73 M |
| Cost of Revenue |
$119.64 M
|
$89.81 M
|
$98.55 M
|
| Gross Profit |
$468.22 M
|
$300.59 M
|
$194.18 M
|
| Gross Profit Ratio |
0.8
|
0.77
|
0.66
|
| Research and Development Expenses |
$368.14 M
|
$97.49 M
|
$110.06 M
|
| General & Administrative Expenses |
$329.51 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$316.95 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$646.46 M
|
$227.54 M
|
$214.64 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$1.01 B
|
$325.02 M
|
$324.69 M
|
| Cost And Expenses |
$1.13 B
|
$414.83 M
|
$423.24 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$5.13 M
|
$5.95 M
|
$5.63 M
|
| EBITDA |
-$541.24 M |
-$5.31 M |
-$102.92 M |
| EBITDA Ratio |
-0.92
|
-0.01
|
-0.35
|
| Operating Income Ratio |
-0.93
|
-0.06
|
-0.45
|
| Total Other Income/Expenses Net |
$19.11 M
|
$13.17 M
|
$21.97 M
|
| Income Before Tax |
-$527.26 M
|
-$11.26 M
|
-$108.55 M
|
| Income Before Tax Ratio |
-0.9
|
-0.03
|
-0.37
|
| Income Tax Expense |
$998.00 K
|
$677.00 K
|
-$405.00 K
|
| Net Income |
-$528.26 M
|
-$11.93 M
|
-$108.14 M
|
| Net Income Ratio |
-0.9
|
-0.03
|
-0.37
|
| EPS |
-5.36 |
-0.15 |
-1.39 |
| EPS Diluted |
-5.19 |
-0.15 |
-1.39 |
| Weighted Average Shares Out |
$79.19 M
|
$78.02 M
|
$78.02 M
|
| Weighted Average Shares Out Diluted |
$81.70 M
|
$78.02 M
|
$78.02 M
|
| Link |
|
|
|
